Stay updated on Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedOvarian cancer and related MedlinePlus Genetics topics were removed from the MedlinePlus related topics section.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedLast update timestamp for the study record was refreshed; core study content such as eligibility, treatment arms, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check30 days agoChange DetectedAdded new MedlinePlus Genetics topic: Ovarian cancer; no deletions.SummaryDifference0.2%

- Check37 days agoChange DetectedUpdated government operating-status notice and timeline with new future dates and a new revision tag; removed some past dates and related genetics topic.SummaryDifference4%

- Check44 days agoChange DetectedThe page shifts from Genetic and Rare Diseases Information Center to MedlinePlus Genetics branding, updates related topics, adds numerous contact numbers, and increases revision from v3.0.2 to v3.1.0.SummaryDifference0.6%

- Check52 days agoChange DetectedRemoved MedlinePlus Genetics topic on Ovarian cancer; reduces coverage of ovarian cancer genetics on the page.SummaryDifference0.2%

Stay in the know with updates to Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.